MSB 1.81% $1.13 mesoblast limited

Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-385

  1. 1,159 Posts.
    lightbulb Created with Sketch. 127
    Yeah nah yeh on the koolaid in a big way hey old sport? old bean? old lad?

    "A new study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average cost was $1.3 billion, which was much lower compared to previous studies, which have placed the average cost of drug development as $2.8 billion."

    https://www.lshtm.ac.uk/newsevents/news/2020/average-cost-developing-new-drug-could-be-15-billion-less-pharmaceutical
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
0.020(1.81%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.12 $1.14 $1.12 $4.898M 4.355M

Buyers (Bids)

No. Vol. Price($)
3 596693 $1.12
 

Sellers (Offers)

Price($) Vol. No.
$1.13 50805 4
View Market Depth
Last trade - 16.10pm 04/06/2024 (20 minute delay) ?
Last
$1.13
  Change
0.020 ( 0.92 %)
Open High Low Volume
$1.12 $1.14 $1.12 1420559
Last updated 15.59pm 04/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.